Evidence map›Paper›PMID 11805146›Full record

ArticleThe Journal of experimental medicine2002

Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation.

Kazunori Inabe, Masamichi Ishiai, Andrew M Scharenberg, Norman Freshney, Julian Downward, Tomohiro Kurosaki

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 142 citations in OpenAlex.

  1. Review
  2. Article
  3. Cells · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. The regulators of BCR signaling during B cell activation.Blood science (Baltimore, Md.) · 2019
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Pathway Analysis of Genome-wide Association Study in Childhood Leukemia among Hispanics.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  16. Article
  17. The multifaceted role of PIP2 in leukocyte biology.Cellular and molecular life sciences : CMLS · 2015
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Kazunori InabeDepartment of Molecular Genetics, Institute for Liver Research, Kansai Medical University, Moriguchi 570-8506, Japan.
Masamichi Ishiai
Andrew M Scharenberg
Norman Freshney
Julian Downward
Tomohiro Kurosaki
Kansai Medical University · JPThe Honourable Society of Lincoln's Inn · GBRIKEN Center for Integrative Medical Sciences · JPUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To elucidate the mechanism(s) by which Vav3, a new member of the Vav family proteins, participates in B cell antigen receptor (BCR) signaling, we have generated a B cell line deficient in Vav3. Here we report that Vav3 influences phosphoinositide 3-kinase (PI3K) function through Rac1 in that phosphatidylinositol-3,4,5-trisphosphate (PIP3) generation was attenuated by loss of Vav3 or by expression of a dominant negative form of Rac1. The functional interaction between PI3K and Rac1 was also demonstrated by increased PI3K activity in the presence of GTP-bound Rac1. In addition, we show that defects of calcium mobilization and c-Jun NH2-terminal kinase (JNK) activation in Vav3-deficient cells are relieved by deletion of a PIP3 hydrolyzing enzyme, SH2 domain-containing inositol polyphosphate 5'-phosphatase (SHIP). Hence, our results suggest a role for Vav3 in regulating the B cell responses by promoting the sustained production of PIP3 and thereby calcium flux.

Indexed as

Cell Cycle ProteinsAnimalsCalciumCell LineChickensGuanine Nucleotide Exchange FactorsHumansPhosphatidylinositol 3-KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-vavrac1 GTP-Binding ProteinReceptors, Antigen, B-CellSignal TransductionCalciumCell Cycle ProteinsGuanine Nucleotide Exchange FactorsPhosphatidylinositol 3-KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-vavrac1 GTP-Binding ProteinReceptors, Antigen, B-CellVAV3 protein, human

Identifiers

PMID11805146
PMCPMC2193613
OpenAlexW2142977472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.